The Johns Hopkins-created maps provide higher resolution and better coverage of gray matter than previously published maps, ...
There’s a mysterious energy quietly influencing your brain. Could it explain where your consciousness originates?
From headphones that can tell the age of your brain to a headband that can help rewire your brain, consumer neurotechnology devices are unraveling the mysteries of the mind ...
Professor of neurosurgery details unexplainable phenomena regarding mind-brain relationship during recent Cornell University ...
Johns Hopkins scientists say they have used 3D imaging, special microscopes and artificial intelligence (AI) programs to construct new maps of mouse ...
Morning Overview on MSN
Some brain cells resist dementia and scientists finally cracked the code
Researchers have identified a specific protein complex inside neurons that tags toxic tau fragments for destruction, offering the clearest explanation yet for why certain brain cells survive while ...
Morning Overview on MSN
Common trauma type found to radically rewire brain chemistry
Childhood abuse, one of the most commonly reported traumatic exposures in the United States, does not merely leave psychological scars. A growing body of postmortem brain studies and clinical ...
India Today on MSN
What can friction-maxxing teach you about life in 2026? A lot
We've made life too easy, and our brains are paying the price. In 2026, friction-maxxing is emerging as the self-improvement ...
The longevity industry has reached an inflection point. With companies like Function Health raising hundreds of millions in venture capital, biological age testing has moved from academic curiosity to ...
A conductive bioadhesive inspired by the ability of mussels to cling to rocks even in moist environments has been developed.
Bibi Boyce talks to experts and students about the female experiences of ADHD “If you’ve met one person with ADHD, then you’ve met one person with ADHD.” These are the words of Dr Helen Duncan, the ...
Novo Nordisk advanced coramitug into the Phase III CLEOPATTRA trial, evaluating 1,280 patients with amyloid transthyretin cardiomyopathy or ATTR-CM. This decision was informed by results from their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results